Reata Pharma (RETA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RETA | XENE | PTCT | ||
| Company | Reata Pharma | Xenon Pharmaceuticals Inc | Ptc Therapeutics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 172.34 | 66.20 | 77.52 | ||
| High | 172.46 | 69.58 | 79.41 | ||
| Low | 172.32 | 66.18 | 77.47 | ||
| Latest | 172.36 | 68.26 | 78.59 | ||
| Change | +0.04 | +1.28 | +0.07 | ||
| % Change | +0.02% | +1.91% | +0.09% | ||
| Volume | 1,988,500 | 1,342,600 | 704,100 | ||
| 20-Day Average Volume | 810,510 | 2,029,700 | 2,345,445 | ||
| Previous Close | 172.32 | 66.98 | 78.52 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 170.84 | 62.39 | 82.81 | ||
| 20-Day Raw Stochastic | 97.36% | 78.14% | 14.25% | ||
| 20-Day Relative Strength | 81.56 | 68.84 | 49.87 | ||
| Weighted Alpha | +177.60 | +99.60 | +54.59 | ||
| Today's Opinion | 100% Buy | 100% Buy | 64% Buy | ||
| Previous Opinion | 100% Buy | 100% Buy | 64% Buy | ||
| Last Month's Opinion | 100% Buy | 40% Buy | 72% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.18% since 09/18/23 | -0.96% since 07/10/26 | -7.38% since 07/10/26 | ||
| Low | 171.96 on 09/19/23 | 65.53 on 07/13/26 | 76.55 on 07/15/26 | ||
| High | 172.46 on 09/25/23 | 69.58 on 07/17/26 | 83.68 on 07/13/26 | ||
| 1-Month | |||||
| %Chg | +1.99% since 08/25/23 | +28.31% since 06/17/26 | +0.08% since 06/17/26 | ||
| Low | 168.67 on 09/05/23 | 52.53 on 06/18/26 | 76.55 on 07/15/26 | ||
| High | 172.46 on 09/25/23 | 72.66 on 07/09/26 | 90.87 on 07/09/26 | ||
| 3-Month | |||||
| %Chg | +83.77% since 06/23/23 | +14.34% since 04/17/26 | +8.50% since 04/17/26 | ||
| Low | 88.80 on 06/27/23 | 50.91 on 06/08/26 | 63.18 on 05/01/26 | ||
| High | 172.46 on 09/25/23 | 72.66 on 07/09/26 | 90.87 on 07/09/26 | ||
| 6-Month | |||||
| %Chg | +101.14% since 03/24/23 | +70.74% since 01/16/26 | +8.43% since 01/16/26 | ||
| Low | 76.54 on 05/10/23 | 39.29 on 01/20/26 | 61.43 on 03/06/26 | ||
| High | 172.46 on 09/25/23 | 72.66 on 07/09/26 | 90.87 on 07/09/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 6,575,535 | 6,598,421 | 6,518,961 | ||
| Shares Outstanding, K | 38,150 | 96,666 | 82,949 | ||
| Annual Sales | 2,220,000 | 7,500,000 | 1,730,660,000 | ||
| Annual Net Income | -311,900,000 | -345,910,000 | 682,640,000 | ||
| Last Quarter Sales | 22,750,000 | 0 | 272,550,000 | ||
| Last Quarter Net Income | 193,000,000 | -102,300,000 | -2,810,000 | ||
| 60-Month Beta | 1.42 | 0.61 | 0.53 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -2.32 on 08/08/23 | -1.17 on 05/07/26 | -0.03 on 05/07/26 | ||
| Earnings Date | 11/14/23 | 08/10/26 | 07/30/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||